Skip to content
2000
Volume 24, Issue 4
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Since the commencement of Corona Virus Disease 2019 (COVID-19) pandemic, which has resulted in millions of mortalities globally, the efforts to minimize the damages have equally been up to the task. One of those efforts includes the mass vaccine development initiative targeting the deadly Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). So far, vaccines have tremendously decreased the rate of transmission and infection in most parts of the world. However, the repeated resurgence of different types of mutated versions of the virus, also known as variants, has somehow created uncertainties about the efficacies of different types of vaccines. This review discusses some of the interesting SARS-CoV-2 features, including general structure, genomics, and mechanisms of variants development and their consequent immune escape. This review also focuses very briefly on antigenic drift, shift, and vaccine-developing platforms.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/0118715265271109231129112515
2024-06-01
2025-05-04
Loading full text...

Full text loading...

/content/journals/iddt/10.2174/0118715265271109231129112515
Loading

  • Article Type:
    Review Article
Keyword(s): Antigenicity; COVID-19; SARS-CoV-2; spike protein; vaccines; variants
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test